1、GBD Disease and Injury Incidence and Prevalence Collaborators.
Global, regional, and national incidence, prevalence, and years lived
with disability for 354 diseases and injuries for 195 countries and
territories, 1990-2017: a systematic analysis for the Global Burden of
Disease Study 2017[ J]. Lancet, 2018, 392(10159): 1789-1858. DOI:
10.1016/S0140-6736(18)32279-7.GBD Disease and Injury Incidence and Prevalence Collaborators.
Global, regional, and national incidence, prevalence, and years lived
with disability for 354 diseases and injuries for 195 countries and
territories, 1990-2017: a systematic analysis for the Global Burden of
Disease Study 2017[ J]. Lancet, 2018, 392(10159): 1789-1858. DOI:
10.1016/S0140-6736(18)32279-7.
2、Strobbe E, Cellini M, Campos EC. Aqueous flare and choroidal
thickness in patients with chronic hepatitis C virus infection: a pilot
study[ J]. Ophthalmology, 2013, 120(11): 2258-2263. DOI: 10.1016/
j.ophtha.2013.03.040.Strobbe E, Cellini M, Campos EC. Aqueous flare and choroidal
thickness in patients with chronic hepatitis C virus infection: a pilot
study[ J]. Ophthalmology, 2013, 120(11): 2258-2263. DOI: 10.1016/
j.ophtha.2013.03.040.
3、Lampignano L, Niro A, Castellana F, et al. Liver fibrosis and retinal
features in an older Mediterranean population: results from the Salus in
Apulia study[ J]. Front Neurosci, 2022, 16: 1048375. DOI: 10.3389/
fnins.2022.1048375.Lampignano L, Niro A, Castellana F, et al. Liver fibrosis and retinal
features in an older Mediterranean population: results from the Salus in
Apulia study[ J]. Front Neurosci, 2022, 16: 1048375. DOI: 10.3389/
fnins.2022.1048375.
4、Chou RH, Lee CY, Chong LW, et al. HBV infection increases the risk
of macular degeneration: the roles of HBx-mediated sensitization of
retinal pigment epithelial cells to UV and blue light irradiation[ J]. J
Transl Med, 2018, 16(1): 221. DOI: 10.1186/s12967-018-1594-4.Chou RH, Lee CY, Chong LW, et al. HBV infection increases the risk
of macular degeneration: the roles of HBx-mediated sensitization of
retinal pigment epithelial cells to UV and blue light irradiation[ J]. J
Transl Med, 2018, 16(1): 221. DOI: 10.1186/s12967-018-1594-4.
5、Roh MI, Kim JH, Byeon SH, et al. Estimated prevalence and risk factor
for age-related maculopathy[ J]. Yonsei Med J, 2008, 49(6): 931-941.
DOI: 10.3349/ymj.2008.49.6.931.Roh MI, Kim JH, Byeon SH, et al. Estimated prevalence and risk factor
for age-related maculopathy[ J]. Yonsei Med J, 2008, 49(6): 931-941.
DOI: 10.3349/ymj.2008.49.6.931.
6、Abe T, Nakajima A, Satoh N, et al. Clinical characteristics of hepatitis C
virus-associated retinopathy[ J]. Jpn J Ophthalmol, 1995, 39(4): 411-
419.Abe T, Nakajima A, Satoh N, et al. Clinical characteristics of hepatitis C
virus-associated retinopathy[ J]. Jpn J Ophthalmol, 1995, 39(4): 411-
419.
7、Yeh CC, Wu MM, Wu CM, et al. Increased risk of age-related macular
degeneration with chronic hepatitis C virus infection: anationwide
population-based propensity score-matched cohort study in Taiwan[ J].
Viruses, 2021, 13(5): 790. DOI: 10.3390/v13050790.Yeh CC, Wu MM, Wu CM, et al. Increased risk of age-related macular
degeneration with chronic hepatitis C virus infection: anationwide
population-based propensity score-matched cohort study in Taiwan[ J].
Viruses, 2021, 13(5): 790. DOI: 10.3390/v13050790.
8、Targher G, Bertolini L, Chonchol M, et al. Non-alcoholic fatty liver
disease is independently associated with an increased prevalence of
chronic kidney disease and retinopathy in type 1 diabetic patients[ J].
Diabetologia, 2010, 53(7): 1341-1348. DOI: 10.1007/s00125-010-
1720-1.Targher G, Bertolini L, Chonchol M, et al. Non-alcoholic fatty liver
disease is independently associated with an increased prevalence of
chronic kidney disease and retinopathy in type 1 diabetic patients[ J].
Diabetologia, 2010, 53(7): 1341-1348. DOI: 10.1007/s00125-010-
1720-1.
9、Targher G, Bertolini L, Rodella S, et al. Non-alcoholic fatty liver
disease is independently associated with an increased prevalence of
chronic kidney disease and proliferative/laser-treated retinopathy in
type 2 diabetic patients[ J]. Diabetologia, 2008, 51(3): 444-450. DOI:
10.1007/s00125-007-0897-4.Targher G, Bertolini L, Rodella S, et al. Non-alcoholic fatty liver
disease is independently associated with an increased prevalence of
chronic kidney disease and proliferative/laser-treated retinopathy in
type 2 diabetic patients[ J]. Diabetologia, 2008, 51(3): 444-450. DOI:
10.1007/s00125-007-0897-4.
10、Kim BY, Jung CH, Mok JO, et al. Prevalences of diabetic retinopathy
and nephropathy are lower in Korean type 2 diabetic patients with nonalcoholic fatty liver disease[ J]. J Diabetes Investig, 2014, 5(2): 170-
175. DOI: 10.1111/jdi.12139.Kim BY, Jung CH, Mok JO, et al. Prevalences of diabetic retinopathy
and nephropathy are lower in Korean type 2 diabetic patients with nonalcoholic fatty liver disease[ J]. J Diabetes Investig, 2014, 5(2): 170-
175. DOI: 10.1111/jdi.12139.
11、Lv WS, Sun RX, Gao YY, et al. Nonalcoholic fatty liver disease
and microvascular complications in type 2 diabetes[ J]. World J
Gastroenterol, 2013, 19(20): 3134-3142. DOI: 10.3748/wjg.v19.
i20.3134.Lv WS, Sun RX, Gao YY, et al. Nonalcoholic fatty liver disease
and microvascular complications in type 2 diabetes[ J]. World J
Gastroenterol, 2013, 19(20): 3134-3142. DOI: 10.3748/wjg.v19.
i20.3134.
12、Afarideh M, Aryan Z, Ghajar A, et al. Association of non-alcoholic fatty
liver disease with microvascular complications of type 2 diabetes[ J].
Prim Care Diabetes, 2019, 13(6): 505-514. DOI: 10.1016/
j.pcd.2019.03.009.Afarideh M, Aryan Z, Ghajar A, et al. Association of non-alcoholic fatty
liver disease with microvascular complications of type 2 diabetes[ J].
Prim Care Diabetes, 2019, 13(6): 505-514. DOI: 10.1016/
j.pcd.2019.03.009.
13、Reichenbach A, Fuchs U, Kasper M, et al. Hepatic retinopathy:
morphological features of retinal glial (Müller) cells accompanying
hepatic failure[ J]. Acta Neuropathol, 1995, 90(3): 273-281. DOI:
10.1007/BF00296511.Reichenbach A, Fuchs U, Kasper M, et al. Hepatic retinopathy:
morphological features of retinal glial (Müller) cells accompanying
hepatic failure[ J]. Acta Neuropathol, 1995, 90(3): 273-281. DOI:
10.1007/BF00296511.
14、Uhlmann S, Uhlmann D, Hauss J, et al. Recovery from hepatic
retinopathy after liver transplantation[ J].Albrecht Von Graefes Arch
Fur Klin Und Exp Ophthalmol, 2003, 241(6): 451-457. DOI: 10.1007/
s00417-003-0639-3.Uhlmann S, Uhlmann D, Hauss J, et al. Recovery from hepatic
retinopathy after liver transplantation[ J].Albrecht Von Graefes Arch
Fur Klin Und Exp Ophthalmol, 2003, 241(6): 451-457. DOI: 10.1007/
s00417-003-0639-3.
15、Dittmer K, Nolte W, Tondrow M, et al. Pathologic fundus changes in
advanced liver cirrhosis. Reduction of symptoms after portosystemic
shunt[ J]. Ophthalmologe, 1998, 95(6): 404-407. DOI: 10.1007/
s003470050288.Dittmer K, Nolte W, Tondrow M, et al. Pathologic fundus changes in
advanced liver cirrhosis. Reduction of symptoms after portosystemic
shunt[ J]. Ophthalmologe, 1998, 95(6): 404-407. DOI: 10.1007/
s003470050288.
16、Abd Elaziz MS, Nada ASE, ElSayed SH, et al. Ocular comorbidities with direct-acting antiviral treatment for chronic hepatitis C virus
(HCV) patients[ J]. Int Ophthalmol, 2020, 40(5): 1245-1251. DOI:
10.1007/s10792-020-01290-y.Abd Elaziz MS, Nada ASE, ElSayed SH, et al. Ocular comorbidities with direct-acting antiviral treatment for chronic hepatitis C virus
(HCV) patients[ J]. Int Ophthalmol, 2020, 40(5): 1245-1251. DOI:
10.1007/s10792-020-01290-y.
17、Ikebe T, Nakatsuka K, Goto M, et al. A case of retinopathy induced by
intravenous administration of interferon [ J]. Folia Ophthalmologica
Japonica, 1990, 41(12): 2291-2296.Ikebe T, Nakatsuka K, Goto M, et al. A case of retinopathy induced by
intravenous administration of interferon [ J]. Folia Ophthalmologica
Japonica, 1990, 41(12): 2291-2296.
18、Schulman JA, Liang C, Kooragayala LM, et al. Posterior segment
complications in patients with hepatitis C treated with interferon and
ribavirin[ J]. Ophthalmology, 2003, 110(2): 437-442. DOI: 10.1016/
S0161-6420(02)01741-4.Schulman JA, Liang C, Kooragayala LM, et al. Posterior segment
complications in patients with hepatitis C treated with interferon and
ribavirin[ J]. Ophthalmology, 2003, 110(2): 437-442. DOI: 10.1016/
S0161-6420(02)01741-4.
19、Saito H, Ebinuma H, Nagata H, et al. Interferon-associated retinopathy
in a uniform regimen of natural interferon-alpha therapy for chronic
hepatitis C[ J]. Liver, 2001, 21(3): 192-197. DOI: 10.1034/j.1600-
0676.2001.021003192.x.Saito H, Ebinuma H, Nagata H, et al. Interferon-associated retinopathy
in a uniform regimen of natural interferon-alpha therapy for chronic
hepatitis C[ J]. Liver, 2001, 21(3): 192-197. DOI: 10.1034/j.1600-
0676.2001.021003192.x.
20、Kadayifcilar S, Boyacioglu S, Kart H, et al. Ocular complications with
high-dose interferon alpha in chronic active hepatitis[ J]. Eye, 1999, 13(
Pt 2): 241-246. DOI: 10.1038/eye.1999.59.Kadayifcilar S, Boyacioglu S, Kart H, et al. Ocular complications with
high-dose interferon alpha in chronic active hepatitis[ J]. Eye, 1999, 13(
Pt 2): 241-246. DOI: 10.1038/eye.1999.59.
21、Hayasak a S, Fujii M , Yamamoto Y, et al . R et inopathy and
subconjunctival haemorrhage in patients with chronic viral hepatitis
receiving interferon Alfa[ J]. Br J Ophthalmol, 1995, 79(2): 150-152.
DOI: 10.1136/bjo.79.2.150.Hayasak a S, Fujii M , Yamamoto Y, et al . R et inopathy and
subconjunctival haemorrhage in patients with chronic viral hepatitis
receiving interferon Alfa[ J]. Br J Ophthalmol, 1995, 79(2): 150-152.
DOI: 10.1136/bjo.79.2.150.
22、d'Alteroche L, Majzoub S, Lecuyer AI, et al. Ophthalmologic side
effects during alpha-interferon therapy for viral hepatitis[ J]. J Hepatol,
2006, 44(1): 56-61. DOI: 10.1016/j.jhep.2005.07.026.d'Alteroche L, Majzoub S, Lecuyer AI, et al. Ophthalmologic side
effects during alpha-interferon therapy for viral hepatitis[ J]. J Hepatol,
2006, 44(1): 56-61. DOI: 10.1016/j.jhep.2005.07.026.
23、Manesis EK, Moschos M, Brouzas D, et al. Neurovisual impairment:
a frequent complication of alpha-interferon treatment in chronic viral
hepatitis[ J]. Hepatology, 1998, 27(5): 1421-1427. DOI: 10.1002/
hep.510270533.Manesis EK, Moschos M, Brouzas D, et al. Neurovisual impairment:
a frequent complication of alpha-interferon treatment in chronic viral
hepatitis[ J]. Hepatology, 1998, 27(5): 1421-1427. DOI: 10.1002/
hep.510270533.
24、Roberti G, Oddone F, Agnifili L, et al. Steroid-induced glaucoma:
Epidemiology, pathophysiology, and clinical management[ J].
Surv Ophthalmol, 2020, 65(4): 458-472. DOI: 10.1016/
j.survophthal.2020.01.002.Roberti G, Oddone F, Agnifili L, et al. Steroid-induced glaucoma:
Epidemiology, pathophysiology, and clinical management[ J].
Surv Ophthalmol, 2020, 65(4): 458-472. DOI: 10.1016/
j.survophthal.2020.01.002.
25、Lei H, Zeng J, Liu X, et al. Analysis of clinical features of tacrolimusinduced optic neuropathy[ J]. J Clin Pharm Ther, 2022, 47(8): 1218-
1224. DOI: 10.1111/jcpt.13658.Lei H, Zeng J, Liu X, et al. Analysis of clinical features of tacrolimusinduced optic neuropathy[ J]. J Clin Pharm Ther, 2022, 47(8): 1218-
1224. DOI: 10.1111/jcpt.13658.
26、Egli A, Bergamin O, Müllhaupt B, et al. Cytomegalovirus-associated
chorioretinitis after liver transplantation: case report and review of the
literature[ J]. Transpl Infect Dis, 2008, 10(1): 27-43. DOI: 10.1111/
j.1399-3062.2007.00285.x.Egli A, Bergamin O, Müllhaupt B, et al. Cytomegalovirus-associated
chorioretinitis after liver transplantation: case report and review of the
literature[ J]. Transpl Infect Dis, 2008, 10(1): 27-43. DOI: 10.1111/
j.1399-3062.2007.00285.x.
27、VerdonW. The retina in systemic disease: a color manual of
ophthalmoscopy[ J]. OptomVisSci, 2010, 87(10): E797. DOI: 10.1097/opx.0b013e3181f8d66e.VerdonW. The retina in systemic disease: a color manual of
ophthalmoscopy[ J]. OptomVisSci, 2010, 87(10): E797. DOI: 10.1097/opx.0b013e3181f8d66e.
28、Snead MP, Rubinstein MP, Jacobs PM. The optics of fundus
examination[ J]. Surv Ophthalmol, 1992, 36(6): 439-445. DOI:
10.1016/s0039-6257(05)80025-6.Snead MP, Rubinstein MP, Jacobs PM. The optics of fundus
examination[ J]. Surv Ophthalmol, 1992, 36(6): 439-445. DOI:
10.1016/s0039-6257(05)80025-6.
29、Jayanna S, Padhi TR , Nedhina EK, et al. Color fundus imaging
in retinopathy of prematurity screening: present and future[ J].
Indian J Ophthalmol, 2023, 71(5): 1777-1782. DOI: 10.4103/IJO.
IJO_2913_22.Jayanna S, Padhi TR , Nedhina EK, et al. Color fundus imaging
in retinopathy of prematurity screening: present and future[ J].
Indian J Ophthalmol, 2023, 71(5): 1777-1782. DOI: 10.4103/IJO.
IJO_2913_22.
30、Liccardo D, Mosca A, Petroni S, et al. The association between retinal
microvascular changes, metabolic risk factors, and liver histology in
pediatric patients with non-alcoholic fatty liver disease (NAFLD)[ J].
J Gastroenterol, 2015, 50(8): 903-912. DOI: 10.1007/s00535-014-
1024-1.Liccardo D, Mosca A, Petroni S, et al. The association between retinal
microvascular changes, metabolic risk factors, and liver histology in
pediatric patients with non-alcoholic fatty liver disease (NAFLD)[ J].
J Gastroenterol, 2015, 50(8): 903-912. DOI: 10.1007/s00535-014-
1024-1.
31、Gifford FJ, Moroni F, Farrah TE, et al. The eye as a non-invasive
window to the microcirculation in liver cirrhosis: aprospective pilot
study[ J]. J Clin Med, 2020, 9(10): 3332. DOI: 10.3390/jcm9103332.Gifford FJ, Moroni F, Farrah TE, et al. The eye as a non-invasive
window to the microcirculation in liver cirrhosis: aprospective pilot
study[ J]. J Clin Med, 2020, 9(10): 3332. DOI: 10.3390/jcm9103332.
32、Sar%C4%B1g%C3%BCl%20Sezen%C3%B6z%20A%2C%20Tortumlu%20G%2C%20Akkoyun%20I%2C%20et%20al.%20Macular%20vessel%20%0Adensity%20measurement%20in%20pediatric%20renal%20and%20liver%20transplant%5B%20J%5D.%20Exp%20%0AClin%20Transplant%2C%202022%2C%2020(Suppl%203)%3A%2089-95.%20DOI%3A%2010.6002%2Fect.%0APediatricSymp2022.O31.Sar%C4%B1g%C3%BCl%20Sezen%C3%B6z%20A%2C%20Tortumlu%20G%2C%20Akkoyun%20I%2C%20et%20al.%20Macular%20vessel%20%0Adensity%20measurement%20in%20pediatric%20renal%20and%20liver%20transplant%5B%20J%5D.%20Exp%20%0AClin%20Transplant%2C%202022%2C%2020(Suppl%203)%3A%2089-95.%20DOI%3A%2010.6002%2Fect.%0APediatricSymp2022.O31.
33、Gkotsi D, Gupta M, Lascaratos G, et al. Alcoholic liver disease and
bilateral multifocal central serous retinopathy: a case report[ J]. J Med
Case Rep, 2013, 7: 43. DOI: 10.1186/1752-1947-7-43.Gkotsi D, Gupta M, Lascaratos G, et al. Alcoholic liver disease and
bilateral multifocal central serous retinopathy: a case report[ J]. J Med
Case Rep, 2013, 7: 43. DOI: 10.1186/1752-1947-7-43.
34、Eckstein AK, Reichenbach A, Jacobi P, et al. Hepatic retinopathia.
Changes in retinal function[ J]. Vision Res, 1997, 37(12): 1699-1706.
DOI: 10.1016/s0042-6989(96)00318-5.Eckstein AK, Reichenbach A, Jacobi P, et al. Hepatic retinopathia.
Changes in retinal function[ J]. Vision Res, 1997, 37(12): 1699-1706.
DOI: 10.1016/s0042-6989(96)00318-5.
35、Langwi%C5%84ska-Wo%C5%9Bko%20E%2C%20Litwin%20T%2C%20Szulborski%20K%2C%20et%20al.%20Optical%20coherence%20%0Atomography%20and%20electrophysiology%20of%20retinal%20and%20visual%20pathways%20in%20%0AWilson's%20disease%5B%20J%5D.%20Metab%20Brain%20Dis%2C%202016%2C%2031(2)%3A%20405-415.%20DOI%3A%20%0A10.1007%2Fs11011-015-9776-8.Langwi%C5%84ska-Wo%C5%9Bko%20E%2C%20Litwin%20T%2C%20Szulborski%20K%2C%20et%20al.%20Optical%20coherence%20%0Atomography%20and%20electrophysiology%20of%20retinal%20and%20visual%20pathways%20in%20%0AWilson's%20disease%5B%20J%5D.%20Metab%20Brain%20Dis%2C%202016%2C%2031(2)%3A%20405-415.%20DOI%3A%20%0A10.1007%2Fs11011-015-9776-8.
36、Simó M, Barsi P, Arányi Z. Predictive role of evoked potential
examinations in patients with clinically isolated optic neuritis in light
of the revised McDonald criteria[ J]. Mult Scler, 2008, 14(4): 472-478.
DOI: 10.1177/1352458507085061.Simó M, Barsi P, Arányi Z. Predictive role of evoked potential
examinations in patients with clinically isolated optic neuritis in light
of the revised McDonald criteria[ J]. Mult Scler, 2008, 14(4): 472-478.
DOI: 10.1177/1352458507085061.
37、Xiao W, Huang X , Wang JH, et al. Screening and identif ying
hepatobiliary diseases through deep learning using ocular images: a
prospective, multicentre study[ J]. Lancet Digit Health, 2021, 3(2):
e88-e97. DOI: 10.1016/S2589-7500(20)30288-0.Xiao W, Huang X , Wang JH, et al. Screening and identif ying
hepatobiliary diseases through deep learning using ocular images: a
prospective, multicentre study[ J]. Lancet Digit Health, 2021, 3(2):
e88-e97. DOI: 10.1016/S2589-7500(20)30288-0.
